✦ LIBER ✦

Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6

✍ Scribed by H. Hadidi; Y. Irshaid; C. Broberg Vågbø; A. Brunsvik; S. Cholerton; K. Zahlsen; J. R. Idle

Publisher: Springer
Year: 1998
Tongue: English
Weight: 202 KB
Volume: 54
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050489

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of a null allele of cytoc

Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population

✍ Sang Seop Lee; Hyun-Ju Jung; Jung Soon Park; In-June Cha; Doo-Yeoun Cho; Jae-Goo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 239 KB

Lack of association between a functional

Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia

✍ Schulze, Thomas G. ;Schumacher, Johannes ;Müller, Daniel J. ;Krauss, Harald ;Alf 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Some mutations of exon-7 in cytochrome P

Some mutations of exon-7 in cytochrome P450 gene 3A4 and their effect on 6β-hydroxylation of cortisol

✍ E. G. Shchepotina; V. A. Vavilin; O. B. Goreva; V. V. Lyakhovich 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 292 KB

In vitro comparative inhibition profiles

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

✍ C. Transon; T. Leemann; P. Dayer 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 343 KB

Validation of higher-throughput high-per

Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes

✍ Inhou Chu; Leonard Favreau; Tony Soares; Chin-chung Lin; Amin A. Nomeir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

In the early stage of drug discovery, thousands of new chemical entities (NCEs) may be screened before a single drug candidate can be identified for development. In order to accelerate the drug discovery process, we have developed higher-throughput enzyme assays to evaluate the inhibition of cytochr